AMLODIPIN Mepha cpr 5 mg 100 pce
7680569910045
CH-56991
C08CA01
02.06.1.
1 / 3
google
Details
- Product number
- 5699101
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- amlodipinum 5 mg ut amlodipini mesilas monohydricus 6.395 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum A corresp. natrium 0.17 mg, magnesii stearas, pro compresso.
Articles (1)
Amlodipin-Mepha 5, Tabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
6.395 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.17 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 35.85
Specialties list
Yes
Generic
Yes
SL addition date:
01/04/2005
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 56991
- Drug name
- Amlodipin-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- C08CA01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/02/2005
- Authorization expiration date
- 31/12/9999
- IT number
- 02.06.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AMLODIPIN Mepha cpr 5 mg 100 pce
- Description (DE)
- AMLODIPIN Mepha Tabl 5 mg 100 Stk
- Market launch
- 04/02/2005
- Narcotic (BTM)
- No